Please login to the form below

Lucid Group Communications Limited

Lucid are specialists committed to delivering excellent medical education that changes clinical practice. Our confidence in understanding therapy areas, together with our approach of working closely with experts ensures we develop the most attractive content, adding genuine clinical value.

We aim to exceed client expectations by delivering to excellent standards and by thinking beyond the boundaries. Our consistent delivery has built trust and developed highly productive partnerships.

We do this through:
  • Utilising Lucid’s tools and processes for Expert planning and engagement enabling clients to establish excellent partnership with experts.
  • Aligning the strategic brand needs of clients and the clinical needs of Experts to develop clinically relevant programmes that are passionately delivered by Experts.

Areas of Expertise

Our experience spans US, EU and UK and we pride ourselves not only on Expert identification and profiling, Expert planning, strategic planning and programme development but additionally on delivering initiatives such as international expert-agreed, evidence-based consensus programmes, Expert Exchanges, Guideline initiatives, publication planning, Advisory Boards, Medical education meetings, DELPHI and modified DELPHI programmes, patient websites and documentaries and so much more.

The team at Lucid have a range of experience in a large number of therapy areas: Oncology, Diabetes, Dermatology, HIV, Gastroenterology, Cardiology, Neurology, Virology, Respiratory, Nutrition, Nephrology, Immunology, Ophthalmology, Rheumatology, Microbiology, Osteology, Hypertension , Pain management, Pathology, CNS, Critical Care, Infectious Diseases e.g. Hepatitis, Herpes Virus and are always willing to learn about new therapy areas!


  • Abbott
  • AbbVie
  • Arthrocare
  • AstraZeneca
  • Bayer
  • Biogen
  • BRIDGe
  • Crohn's and Colitis Foundation of Canada
  • Eisai
  • Genzyme
  • Genus
  • Gilead
  • GSK
  • Leo Pharma
  • Mitsubishi
  • Oxford University
  • Pfizer
  • Quintiles
  • Regeneron
  • Roche
  • Shire


Dennis O'Brien
Dennis O'Brien
Managing director
Jan Steele
Jan Steele
Operations director
Julie Borland
Julie Borland
Therapy director
Clare Reynolds
Clare Reynolds
Therapy director
Nicky Emmett
Nicky Emmett
Senior account director
Alistair Rose
Alistair Rose
Senior account director
Andrea Hamlin
Andrea Hamlin
Programme director, Leading Edge

Press Releases

A summer meeting full of magical moments
Sir Henry presents Queen’s Award for Enterprise to Lucid Group
Lucid Group’s winning formula is recognised at Communiqué 2017
Lucid Partners grows its medical writing team
Using insights to effect behaviour change
All five of Lucid’s entries reach the shortlist for Communiqué 2017
Your career starts here
Are you suffering from templatitis?
It's time to shine for Lucid's rare disease team
Focus on Rare Diseases
As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.
Perfect Timing?
Lucid Group Achieve UK's Highest Award for Business Success
The driving force behind Momentum Strategy
Lucid Partners US changes its name to Lighthouse Medical Communications US
Bring some #LucidLife to your medical education programmes
Lucid Group gains further momentum with launch of new Strategic Consultancy
Cheers to 10 years!
Lucid Group celebrate their 10th birthday in style
We're celebrating 10 years of changing lives with medical education
A view from within #LucidLife
As we celebrate our 10 year anniversary, Joanne shares her #LucidLife journey
The Lucid Winter Summit 2016
2017: Medical education that improves value and outcomes for patients
Lucid Group kick off their Winter Festival
Leading Edge expands their senior medical writing team
Lucid win PMEA Support Agency of the Year 2016
Lucid strengthens its creative services department
Changing behaviour: putting theory into practice
Lucid make the shortlist in all of the four categories they entered for the PMEA programme 2016
Lucid bolsters its senior leadership team
Lucid Group has had a successful summer attracting top talent to its senior leadership team with the appointment of Shula Sarner (Executive Scientific Director) and Tanya Goodyear (Division Director, Immunology).
IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice
Lucid Group becomes a sponsor of MedComms Networking
Tenth Lucid Academy module delivered – nurturing talent and driving excellence
Celebrating the success of the Lucid Academy
Lucid launch new recruitment campaign to attract top talent in medical writing
We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from your everyday experiences, to career progression and job flexibility. So tell us – what would your Lucid Life look like? Contact Dan by email or give him a call. Email: Tel: 01494 755495.
Knowing your audience is key to successful medical education
Making a difference together
Lucid Group take time out for work and play at their annual Summer Meeting
Lucid Group shines at the Communiqué Awards
Developing Medical Education That Advances Patient Outcomes
Future-proofing with a comprehensive talent development strategy
Lucid reach the shortlist for Communiqué 2016 in SIX categories
Lucid Co-founder and COO discusses the changing landscape of healthcare communications
New talent blooms at Lucid Group
The art of changing behaviour with virtual technology
Lucid CEO discusses the importance of company culture
There's never a dull moment at Lucid Group
Lucid Group support local charity event
Why health psychology should inform pharma strategy
Lucid Group celebrate 9 years of changing patients’ lives
It's time to get with the real world
Lucid CEO discusses the increasing importance placed on real-world data to demonstrate value
A Lucid Induction
Lucid Group kick off 2016 with six new employees
Lucid’s digital responsibility: delivering value by improving patient outcomes
Digital initiatives must address your customer's needs
Lucid Group US: moving on up!
New premises for Lucid Group US
Lucid group celebrate outstanding year in style
A well-deserved celebration
Lucid team : because you're worth it!
Lucid group reward the team for an amazing year
Lucid celebrate big wins at PMEA 2015
Success for Lucid at PMEA 2015
Lucid invests in their Futures programme with a new hire
Lucid Group continues their expansion
Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015
Rheumatologists eagerly await trial data for Janus kinase inhibitors
Making a difference to patients with IBD
Changing lives with medical education
Lucid’s motivation to make a difference in medical education drives everything they do
Changing lives with medical education
Lucid Group meets with next generation MedEd talent at University of Oxford Internships Fair
Lucid Group will welcome interns in summer 2016
Lucid Group appoints new MD for Leading Edge
New MD at Leading Edge
Lucid Group showcases new KOL identification and mapping tool
Advancing Expert identification with digital new tool from Lucid Group
Lucid CEO discusses his inspiration and passion for changing patients' lives
Changing patients' lives with innovative methodologies in medical education
Lucid Group starts new trend for CME in IBD education
A tailored educational event in IBD
Lucid Group's new website is launched!
Lucid Group unveil new website...

White Papers and Resources

He who dares wins
The benefits of including medical experts in your brand planning team
Does your medical education drive change in clinical practice?
How to advance outcomes for patients using a medical education process, by Jan Steele PhD, operations director, Lucid
Advance the way you work with your experts
Written by Jan Steele PhD, operations director, Lucid


Latest Tweets